Stereotactic Body Radiation Therapy in Prostate Cancer: Where Do We Stand?
Journal of Current Oncology · 2023
DOI: 10.1177/25898892231200962 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Current Oncology, 2023. Verfasst von Kaustav Talapatra und 4 weiteren Autor:innen. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Stereotactic body radiotherapy (SBRT) is an important option for prostate cancer treatment. It involves the delivery of a high dose of radiation to the malignant tissue without affecting the neighboring healthy tissue to achieve a high therapeutic index. As the cells of prostate cancer are radiobiologically similar to a late-responding tissue with a low 𝛼/𝛽 ratio, the dose escalation approach has a better disease control probability than conventional dose fractionation. Therefore, considering the availability of intensity-modulated RT and possibility of dose escalation (>70 Gy), ultrahypofractionated SBRT is now being recommended in select patients with prostate cancers of low and intermediate risk. Although adverse events following SBRT are a concern, acute toxicity can be limited to a certain extent by adjusting the overall length of treatment time by spacing out RT over multiple fractions. Modern radiation planning and delivery methods used in conjunction with cutting-edge imaging techniques have led to the increased adoption of SBRT in prostate cancer. Thus, from a practical standpoint, it is noninvasive and effective for treating prostate cancer, leading to increased access and higher patient satisfaction.
Zitieren
APA
Talapatra, K., G, K., Mohan, A., Bardeskar, N., & Tongaonkar, H. (2023). Stereotactic Body Radiation Therapy in Prostate Cancer: Where Do We Stand?. Journal of Current Oncology. https://doi.org/10.1177/25898892231200962
Vancouver
Talapatra K, G K, Mohan A, Bardeskar N, Tongaonkar H. Stereotactic Body Radiation Therapy in Prostate Cancer: Where Do We Stand?. Journal of Current Oncology. 2023. doi:10.1177/25898892231200962
BibTeX
@article{Talapatra2023,
author = {Talapatra, Kaustav and G, Kiron and Mohan, Amrutha and Bardeskar, Nikhil and Tongaonkar, Hemant},
title = {Stereotactic Body Radiation Therapy in Prostate Cancer: Where Do We Stand?},
journal = {Journal of Current Oncology},
year = {2023},
doi = {10.1177/25898892231200962}
}
EUVIMED